SARS-CoV-2 Acute Respiratory Disease Clinical Trial
Official title:
A Prospective Cohort Study of Immunoglobulin G (IgG) Dynamics Against SARS-Co
The primary objective of this study is to describe the longevity of IgG against SARS-CoV-2 infection or vaccination.
This virtual clinical study will use a prospective design, to evaluate longevity and seroprevalence of IgG against SARS-CoV-2 in approximately 800 patients as measured by Dried Blood Spots via fingerstick using the Everlywell COVID-19 Antibody Test Home Collection Kit. Participants will be followed up to 9 months at 1, 3, 6 and 9 months after enrollment. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05063214 -
Muscle Evaluation of Patients Infected by the Coronavirus
|
||
| Not yet recruiting |
NCT05013034 -
Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients
|
Phase 2 | |
| Completed |
NCT04998253 -
Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction in ARDS Secondary to SARS-CoV2
|
Early Phase 1 | |
| Active, not recruiting |
NCT05167227 -
Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID and Other Fatiguing Illnesses Improve Clinical Care of Patients and Represent a Sustainable Approach Within a Federally Qualified Health Center?
|
N/A | |
| Withdrawn |
NCT05393999 -
SABRE: A Single-arm Prospective Study Measuring Safety and Tolerability of SARS-CoV-2 Neutralising Antibodies in High-risk Populations
|
Phase 2 | |
| Completed |
NCT05142553 -
Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.
|
Phase 2 | |
| Recruiting |
NCT04929691 -
The CircumVent Project: A CPAP/O2 Helmet Solution for Non-Invasive Ventilation Among Patients With COVID-19
|
N/A | |
| Completed |
NCT05142514 -
Safety and Immunogenicity of Recombinant Protein RBD Fusion Dimer Vaccine Against the Virus That Cause COVID-19, Known as Severe Acute Respiratoy Syndrome Coronavirus 2 (SARS-CoV-2)
|
Phase 2 | |
| Withdrawn |
NCT04894682 -
Safety and Long-term Effects of COVID-19 Vaccines in Patients With Pulmonary Tumor
|
||
| Completed |
NCT04845048 -
Active Pharmacovigilance Study of Adsorbed COVID-19 (Inactivated) Vaccine
|
||
| Completed |
NCT05638178 -
The Corona Study of Middle Norway
|
||
| Not yet recruiting |
NCT05248373 -
Safety, Tolerability and Immunogenicity of Gam-COVID-Vac Vaccine in a Nasal Spray
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05074121 -
NAC for Attenuation of COVID-19 Symptomatology
|
Phase 2 | |
| Completed |
NCT05305573 -
Assessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated With Adenovirus Vaccine Against COVID-19.
|
Phase 2 | |
| Completed |
NCT04896866 -
Efficacy and Safety of Antimicrobial Stewardship Intervention in Hospitalized COVID-19 Patients (COVASP)
|
N/A | |
| Completed |
NCT04371471 -
Pandemic Triage Score in Patients With Known or Suspected Severe Acute Respiratory Syndrome (SARS) CoronaVirus (CoV) 2 Infection
|
||
| Completed |
NCT05008562 -
How COVID-19 Effects to Muscle Mass Change ın ICU?
|
||
| Completed |
NCT04954157 -
Studies to Determine Whether Oxygen Sensing is Impaired in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients
|
N/A | |
| Recruiting |
NCT05133596 -
Study of the Evolution of Olfactory Disorders in Patients With Persistent Loss of Smell Following COVID-19
|
N/A | |
| Withdrawn |
NCT04913142 -
About Oral and Gut Microbiota in Intensive Care Unit : SARS-CoV-2 (COVID-19) Infection Impact.
|